LOW GRADE GLIOMA
Clinical trials for LOW GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new LOW GRADE GLIOMA trials appear
Sign up with your email to follow new studies for LOW GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough cancers: targeted pill shows promise
Disease control CompletedThis study tested a drug called tazemetostat in 20 children whose cancers had come back or weren't responding to treatment. The children had specific gene changes (EZH2 or SWI/SNF) in their tumors. The goal was to see if the drug could shrink or control the cancer. This is a dise…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for kids with tough brain tumors: experimental drug shows promise
Disease control CompletedThis study tested a drug called Tovorafenib in 44 children and young adults with low-grade gliomas (a type of brain tumor) that had come back or not responded to standard treatments. The main goal was to find the safest dose and understand side effects. The drug works by blocking…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE1 • Sponsor: Karen D. Wright, MD • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New imaging agent could sharpen detection of recurrent brain cancer
Diagnosis CompletedThis study tested a special dye called fluoroethyltyrosine (FET) used during a PET scan to see if it can better detect brain tumors that have come back after treatment. Researchers enrolled 143 people with suspected recurrent brain tumors. The goal was to see how accurate the FET…
Matched conditions: LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 13, 2026 15:58 UTC